Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit Robbins LLP is Investigating Allegations that Caribou Biosciences, Inc. (CRBU) Misled Investors Regarding the Efficacy of its Lead Drug Candidate

Caribou Biosciences, Inc. (CRBU) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Caribou Biosciences, Inc. SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who purchased or acquired Caribou...

Caribou Biosciences, Inc. (CRBU) Class Action Alert: Contact Robbins LLP for Information Regarding Class Action Against Caribou Biosciences, Inc. SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who purchased or acquired Caribou...

Caribou Biosciences, Inc. (CRBU) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Caribou Biosciences, Inc. SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who purchased or acquired Caribou...